A story of microalbuminuria and diabetic nephropathy
Context: It is estimated that more than 346 million people worldwide have diabetes mellitus . By the year 2030, it is predicted that diabetes will become the seventh leading cause of death in the world. Development of chronic kidney disease (CKD) in patients with diabetes adds significantly to the m...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Society of Diabetic Nephropathy Prevention
2013-10-01
|
| Series: | Journal of Nephropathology |
| Subjects: | |
| Online Access: | https://nephropathol.com/PDF/jnp-2-234.pdf |
| _version_ | 1827948571871150080 |
|---|---|
| author | Bijan Roshan Robert C. Stanton |
| author_facet | Bijan Roshan Robert C. Stanton |
| author_sort | Bijan Roshan |
| collection | DOAJ |
| description | Context: It is estimated that more than 346 million people worldwide have diabetes mellitus . By the year 2030, it is predicted that diabetes will become the seventh leading cause of death in the world. Development of chronic kidney disease (CKD) in patients with diabetes adds significantly to the morbidity and mortality and significantly increases health care costs, even before the development of end stage renal disease (ESRD). Evidence acquisitions: Directory of Open Access Journals (DOAJ), Google Scholar, Pubmed (NLM), LISTA (EBSCO) and Web of Science have been searched. Results: Diabetic nephropathy (DN) is increasing rapidly worldwide. It is the leading cause of new cases of ESRD in the USA. Interestingly, although DN is the most common cause of ESRD in diabetic patients, diabetes mellitus is also an independent and strong risk factor for ESRD ascribed to causes other than DN (e.g. hypertensive nephropathy). Conclusions: It is important to be aware of the pitfalls of using the urine albumin level in predicting development and progression of diabetic nephropathy in order to treat and advise the patients accurately. Research into finding new markers is rapidly evolving but current progress makes it likely we will be using the urine albumin level for some years into the future. |
| first_indexed | 2024-04-09T12:56:20Z |
| format | Article |
| id | doaj.art-c2a48674a1934b299f16c42494580b0f |
| institution | Directory Open Access Journal |
| issn | 2251-8363 2251-8819 |
| language | English |
| last_indexed | 2024-04-09T12:56:20Z |
| publishDate | 2013-10-01 |
| publisher | Society of Diabetic Nephropathy Prevention |
| record_format | Article |
| series | Journal of Nephropathology |
| spelling | doaj.art-c2a48674a1934b299f16c42494580b0f2023-05-13T11:42:48ZengSociety of Diabetic Nephropathy PreventionJournal of Nephropathology2251-83632251-88192013-10-012423424010.12860/JNP.2013.37JNP_20130930165655A story of microalbuminuria and diabetic nephropathyBijan Roshan0Robert C. Stanton1Division of Renal Diseases and Hypertension, University of Colorado Denver, 12700 East 19th Ave. Room 7015Aurora, CO 80045, USAJoslin Diabetes Center and Harvard Medical School, One Joslin Place, Renal Division. Boston, MA 02215, USAContext: It is estimated that more than 346 million people worldwide have diabetes mellitus . By the year 2030, it is predicted that diabetes will become the seventh leading cause of death in the world. Development of chronic kidney disease (CKD) in patients with diabetes adds significantly to the morbidity and mortality and significantly increases health care costs, even before the development of end stage renal disease (ESRD). Evidence acquisitions: Directory of Open Access Journals (DOAJ), Google Scholar, Pubmed (NLM), LISTA (EBSCO) and Web of Science have been searched. Results: Diabetic nephropathy (DN) is increasing rapidly worldwide. It is the leading cause of new cases of ESRD in the USA. Interestingly, although DN is the most common cause of ESRD in diabetic patients, diabetes mellitus is also an independent and strong risk factor for ESRD ascribed to causes other than DN (e.g. hypertensive nephropathy). Conclusions: It is important to be aware of the pitfalls of using the urine albumin level in predicting development and progression of diabetic nephropathy in order to treat and advise the patients accurately. Research into finding new markers is rapidly evolving but current progress makes it likely we will be using the urine albumin level for some years into the future.https://nephropathol.com/PDF/jnp-2-234.pdfmicroalbuminuriadiabetic nephropathychronic kidney disease |
| spellingShingle | Bijan Roshan Robert C. Stanton A story of microalbuminuria and diabetic nephropathy Journal of Nephropathology microalbuminuria diabetic nephropathy chronic kidney disease |
| title | A story of microalbuminuria and diabetic nephropathy |
| title_full | A story of microalbuminuria and diabetic nephropathy |
| title_fullStr | A story of microalbuminuria and diabetic nephropathy |
| title_full_unstemmed | A story of microalbuminuria and diabetic nephropathy |
| title_short | A story of microalbuminuria and diabetic nephropathy |
| title_sort | story of microalbuminuria and diabetic nephropathy |
| topic | microalbuminuria diabetic nephropathy chronic kidney disease |
| url | https://nephropathol.com/PDF/jnp-2-234.pdf |
| work_keys_str_mv | AT bijanroshan astoryofmicroalbuminuriaanddiabeticnephropathy AT robertcstanton astoryofmicroalbuminuriaanddiabeticnephropathy AT bijanroshan storyofmicroalbuminuriaanddiabeticnephropathy AT robertcstanton storyofmicroalbuminuriaanddiabeticnephropathy |